TABLE 3.
Agents included in this analysis: antibacterials for systemic use (J01), neomycin (A07AA01), streptomycin (A07AA04), polymyxin B (A07AA05), kanamycin (A07AA08), vancomycin (A07AA09), colistin (A07AA10), rifamixin (A07AA11), rifampicin (J04AB02), rifamycin (J04AB03), rifabutin (J04AB04), metronidazole (P01AB01).
The table is sorted according to the number of countries which included the antimicrobial in the DU75%, considering Access (green panel), Watch (yellow panel) and unclassified agents (gray panel) separately (World Health Organization 2019).
*Numbers of countries which have this agent in DU75%.
EU/EEA population-weighted mean for countries of ESAC-Net.
WHO/AMC population-weighted mean for countries of the WHO Europe AMC Network.
The numbers shown in the table refer to the frequency of use, e.g. 1 = most often consumed antimicrobial.